NRG
ZBH icon

Nemes Rush Group’s Zimmer Biomet ZBH Stock Holding History

Nemes Rush Group’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20
Closed -$1.82K – 750
2025
Q2 		$1.82K Hold
20
– – ﹤0.01% 612
2025
Q1 		$2.26K Hold
20
– – ﹤0.01% 597
2024
Q4 		$2.11K Hold
20
– – ﹤0.01% 607
2024
Q3 		$2.64K Hold
20
– – ﹤0.01% 500
2024
Q2 		$2.17K Hold
20
– – ﹤0.01% 511
2024
Q1 		$2.64K Hold
20
– – ﹤0.01% 545
2023
Q4 		$2.43K Hold
20
– – ﹤0.01% 540
2023
Q3 		$2.25K Sell
20
-50
-71% -$6.35K ﹤0.01% 533
2023
Q2 		$10.2K Buy
+70
New +$9.51K ﹤0.01% 423

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Nemes Rush Group's ZBH Position: Q3 2025 in Review

Nemes Rush Group sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 20 shares — an estimated $1.82K sold.

Nemes Rush Group first reported a position in ZBH in Q2 2023 and held it in 9 quarters. The position peaked at $10.2K in Q2 2023. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

  • Nemes Rush Group reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
  • Nemes Rush Group sold 20 Zimmer Biomet shares in Q3 2025, an estimated $1.82K.
  • Nemes Rush Group first reported a position in Zimmer Biomet in Q2 2023 and held it in 9 quarters.
  • Nemes Rush Group's Zimmer Biomet position peaked at $10.2K in Q2 2023.
  • 966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on Nemes Rush Group's 13F filing for Q3 2025, filed 13 Nov 2025.